X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (421) 421
photopheresis (229) 229
index medicus (219) 219
male (214) 214
female (186) 186
hematology (177) 177
extracorporeal photopheresis (170) 170
middle aged (150) 150
photopheresis - methods (148) 148
transplantation (148) 148
adult (146) 146
photochemotherapy (132) 132
graft vs host disease - therapy (130) 130
treatment outcome (104) 104
photopheresis - adverse effects (89) 89
dermatology (86) 86
versus-host-disease (86) 86
chronic disease (81) 81
hematopoietic stem cell transplantation - adverse effects (79) 79
immunology (79) 79
aged (77) 77
extracorporeal photochemotherapy (77) 77
adolescent (72) 72
t-cell lymphoma (68) 68
child (65) 65
therapy (62) 62
care and treatment (57) 57
immunosuppressive agents - therapeutic use (57) 57
graft vs host disease - etiology (55) 55
retrospective studies (53) 53
dendritic cells (51) 51
transplantation, homologous (51) 51
oncology (50) 50
graft-versus-host disease (49) 49
health aspects (47) 47
stem cells (47) 47
regulatory t-cells (45) 45
graft vs host disease - drug therapy (42) 42
t cells (42) 42
cancer (40) 40
risk factors (40) 40
young adult (40) 40
acute disease (39) 39
hematopoietic stem cells (39) 39
survival (38) 38
animals (37) 37
hematology, oncology and palliative medicine (37) 37
stem-cell transplantation (37) 37
bone-marrow-transplantation (36) 36
consensus development project (35) 35
child, preschool (34) 34
gvhd (34) 34
surgery (34) 34
apoptosis (33) 33
clinical-trials (33) 33
immunotherapy (33) 33
diagnosis (32) 32
lymphocytes (32) 32
bone marrow transplantation - adverse effects (31) 31
chronic gvhd (31) 31
sezary-syndrome (31) 31
hematopoietic stem cell transplantation (30) 30
pediatrics (30) 30
combined modality therapy (29) 29
skin (29) 29
skin neoplasms - drug therapy (29) 29
apoptotic cells (28) 28
follow-up studies (28) 28
lymphoma, t-cell, cutaneous - therapy (28) 28
children (27) 27
graft vs host disease - immunology (27) 27
lymphoma, t-cell, cutaneous - drug therapy (27) 27
analysis (25) 25
bronchiolitis obliterans - etiology (25) 25
graft versus host reaction (25) 25
lung transplantation - adverse effects (25) 25
mycophenolate-mofetil (25) 25
rejection (25) 25
survival rate (25) 25
graft rejection - therapy (24) 24
health technology assessment (24) 24
immunosuppression (24) 24
mycosis-fungoides (24) 24
non-hodgkin's lymphomas (24) 24
pediatric-patients (24) 24
aged, 80 and over (23) 23
blood (23) 23
research (23) 23
skin neoplasms - therapy (23) 23
time factors (23) 23
apheresis (22) 22
graft vs host disease - mortality (22) 22
mortality (22) 22
acute gvhd (21) 21
bronchiolitis obliterans - therapy (21) 21
graft-versus-host reaction (21) 21
immunomodulation (21) 21
lymphoma (21) 21
lymphomas (21) 21
prospective studies (21) 21
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (456) 456
German (9) 9
French (6) 6
Russian (3) 3
Spanish (2) 2
Bosnian (1) 1
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Transplant Infectious Disease, ISSN 1398-2273, 04/2017, Volume 19, Issue 2, pp. e12656 - n/a
We describe the first reported pediatric patient to our knowledge with a spindle cell pseudotumor caused by Mycobacterium genavense in a hematopoietic stem... 
spindle cell pseudotumor | Mycobacterium genavense | pediatrics | hematopoietic stem cell transplant | Hematopoietic stem cell transplant | Spindle cell pseudotumor | Pediatrics | INFECTIOUS DISEASES | INFECTION | PATIENT | SKIN | IMMUNOLOGY | KIDNEY | TRANSPLANTATION | Graft vs Host Disease - therapy | Genetic Diseases, X-Linked - surgery | Diarrhea - surgery | Lymph Nodes - pathology | Diabetes Mellitus, Type 1 - surgery | Humans | Immunosuppressive Agents - therapeutic use | Diabetes Mellitus, Type 1 - congenital | Male | Antibiotic Prophylaxis | Melphalan - therapeutic use | Bronchoalveolar Lavage Fluid - microbiology | Histiocytes - microbiology | Mycobacterium Infections, Nontuberculous - pathology | Melphalan - adverse effects | Mycobacterium Infections, Nontuberculous - microbiology | Hematopoietic Stem Cell Transplantation - adverse effects | Polymerase Chain Reaction | Transplantation Conditioning - adverse effects | Photopheresis | Transplantation Conditioning - methods | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Vidarabine - adverse effects | Vidarabine - analogs & derivatives | Alemtuzumab | Vidarabine - therapeutic use | Abdomen | Graft Rejection - surgery | Nontuberculous Mycobacteria - isolation & purification | Cyclosporine - therapeutic use | Immune System Diseases - congenital | Mycophenolic Acid - adverse effects | Mycophenolic Acid - therapeutic use | Cyclosporine - adverse effects | Adolescent | Antibiotics, Antitubercular - therapeutic use | Nontuberculous Mycobacteria - pathogenicity | Bone Marrow Transplantation - adverse effects | Immunosuppressive Agents - adverse effects | Immune System Diseases - surgery | Mycobacterium Infections, Nontuberculous - drug therapy | Lymph Nodes - microbiology | Transplantation | Hematopoietic stem cells | Stem cells
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 8, pp. 1774 - 1787
Abstract Background Chronic graft-versus-host disease (cGvHD) is the leading cause of late nonrelapse mortality (transplant-related mortality) after... 
Internal Medicine | Medical Education | cost-effectiveness | extracorporeal photopheresis | chronic graft | host disease | Host disease | Extracorporeal photopheresis | Cost-effectiveness | Chronic graft | EXTRACORPOREAL PHOTOCHEMOTHERAPY | T-CELL LYMPHOMA | MONOCLONAL-ANTIBODY | TRANSPLANTATION | ECONOMIC-EVALUATION | RITUXIMAB | SALVAGE THERAPY | PHARMACOLOGY & PHARMACY | PHOTOPHERESIS | REFRACTORY CHRONIC GVHD | IMATINIB MESYLATE | Drug Costs | Graft vs Host Disease - therapy | Humans | Immunosuppressive Agents - therapeutic use | Needs Assessment - economics | Photopheresis - economics | Piperazines - economics | Health Services Needs and Demand - economics | Models, Economic | Time Factors | Computer Simulation | Immunosuppressive Agents - economics | Graft vs Host Disease - diagnosis | Graft vs Host Disease - economics | Quality-Adjusted Life Years | Photopheresis - adverse effects | Antibodies, Monoclonal, Murine-Derived - economics | National Health Programs - economics | Rituximab | Treatment Outcome | Piperazines - therapeutic use | Pyrimidines - economics | Imatinib Mesylate | Piperazines - adverse effects | Spain | Health Care Costs | Pyrimidines - therapeutic use | Cost-Benefit Analysis | Pyrimidines - adverse effects | Immunosuppressive Agents - adverse effects | Benzamides | Antibodies, Monoclonal, Murine-Derived - adverse effects | Chronic Disease | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Health Care Rationing - economics | Transplantation | Hematopoietic stem cells | Stem cells | Studies | Transplants & implants | Mortality | Economia de la salut | Espanya | Medical economics
Journal Article
Leukemia, ISSN 0887-6924, 2015, Volume 29, Issue 10, pp. 2062 - 2068
Despite major improvements in allogeneic hematopoietic cell transplantation over the past decades, corticosteroid-refractory (SR) acute (a) and chronic (c)... 
ANTITHYMOCYTE GLOBULIN THERAPY | FACTOR-RECEPTOR | RESISTANT | MARROW | ONCOLOGY | ACUTE GVHD | EXTRACORPOREAL PHOTOPHERESIS | CYTOKINE INHIBITION | TOFACITINIB | COMBINATION | HEMATOLOGY | MYCOPHENOLATE-MOFETIL | Hematologic Neoplasms - therapy | Recurrence | Pyrazoles - therapeutic use | Prognosis | Follow-Up Studies | Humans | Middle Aged | Salvage Therapy | Male | Transplantation, Homologous | Young Adult | Graft vs Host Disease - mortality | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Retrospective Studies | Hematologic Neoplasms - complications | Graft vs Host Disease - etiology | Disease Models, Animal | Adrenal Cortex Hormones - pharmacology | Survival Rate | Janus Kinases - antagonists & inhibitors | Animals | Graft vs Host Disease - drug therapy | Aged | Mice | Neoplasm Staging | Drug Resistance, Neoplasm - drug effects | Complications and side effects | Oncology, Experimental | Stem cells | Graft versus host reaction | Transplantation | Research | Drug therapy | Cancer | Corticoids | Graft-versus-host reaction | Transplants & implants | Stem cell transplantation | Activation | Inflammation | Anti-inflammatory agents | Hemopoiesis | Confidence intervals | Surveys | Janus kinase | SALVAGE | SURVIVAL | ALEMTUZUMAB | THERAPY | EXTRACORPOREAL | PHOTOPHERESIS | Cancer and Oncology | Cancer och onkologi
Journal Article
Transfusion, ISSN 0041-1132, 06/2011, Volume 51, Issue 6, pp. 1314 - 1320
BACKGROUND: Extracorporeal photopheresis (ECP) is a procedure in which leukocytes are harvested from a patient's whole blood, treated with a DNA binding dye... 
CLINICAL EVENTS | HEMATOLOGY | VERSUS-HOST-DISEASE | EXTRACORPOREAL PHOTOPHERESIS | TRANSPLANTATION | Photopheresis - adverse effects | Humans | Hypertension - chemically induced | Middle Aged | Adult | Female | Heparin - therapeutic use | Aged | Heparin - adverse effects | Databases, Factual | Care and treatment | Anticoagulants (Medicine) | Glycosaminoglycans | Lymphocytes | Patients
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2012, Volume 158, Issue 1, pp. 46 - 61
Journal Article